2024 HCPCS Code M0240
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring, subsequent repeat doses
TAGS: administration intravenous subsequent casirivimab subcutaneous doses imdevimab repeat infusion
Short Description | Casiri and imdev repeat |
HCPCS Coverage Code | C - Carrier judgment |
HCPCS Action Code | N - No maintenance for this code |
HCPCS Action Effective Date | July 30, 2021 |
HCPCS Code Added Date | July 30, 2021 |
HCPCS Pricing Indicator Code | 54 - Vaccinations |
HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
HCPCS Coverage Issues Manual Reference Section Number | |
HCPCS Type Of Service Code | V - Pneumococcal/flu vaccine (eff 01/96), Pneumococcal/flu/hepatitis B vaccine (eff 04/95-12/95), Pneumococcal only before 04/95 |
HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- M1346 - Pts no pam 6 pts 6-12 mo
- M1347 - Pt pam incr 3 pt 6-12 mo
- M1348 - Pt pam incr 6 pt 6-12 mo
- M1349 - Pt no pam 3 pts 6-12 mo
- M1350 - Pt w/ suic saf pln init rev
- M1351 - Pt cmplt suicd saf pln 120dy
- M1352 - Suicd c-ssrs assessment, equ
- M1353 - Pts no cmplt suicd saf pln
- M1354 - Pt no suicd saf pln 120dy
- M1355 - Suicd based cln eval
- M1356 - Pt died dur meas pd
- M1357 - Pt w/red suic idea 120 days
- M1358 - Pts no <suicd idea 120 dys
- M1359 - Indx suicd idea, no 0 scr
- M1360 - Suicd c-ssrs assessment
- M1361 - Suicd based cln eval
- M1362 - Pt died dur meas pd
- M1363 - Pts no f/u 120 dys
- M1364 - Ascvd risk >=20pct
- M1365 - Hosp+pall care spec code 17